Results 191 to 200 of about 50,045 (313)
Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9 [PDF]
, 2019 Curiel, David T +5 more
core +1 more source
Radionuclides in the postoperative management of orthotopic human organ transplantation. [PDF]
, 1969 Brown, DW, Starzl, TE
core +1 more source
New developments in the management of moderate-to-severe hemophilia B
, 2016 John P. Sheehan, Moniba Nazeef
openalex +2 more sources
Case Reports in Hematology, Volume 2026, Issue 1, 2026.Acquired Factor V (FV) deficiency due to inhibitors is a rare coagulopathy that presents significant diagnostic and therapeutic challenges. We report the case of an 81‐year‐old male with persistent gross hematuria and severe coagulopathy, marked by prolonged prothrombin time (PT), activated partial thromboplastin time (aPTT), and critically low FV ...
Shreyas Kalantri +6 more
wiley +1 more source
Hemophilia B With Intracranial Hemorrhage Rehabilitation in High-Dependency Unit: A Case Report. [PDF]
Clin Case RepFeng X, Zhu H, Han L, Xu H, He L.
europepmc +1 more source
Gene therapy in an era of emerging treatment options for hemophilia B
, 2015 Paul E. Monahan
openalex +2 more sources
The Use of Tranexamic Acid to Treat Melasma: A Systematic Review and Meta‐Analysis
Dermatologic Therapy, Volume 2026, Issue 1, 2026.Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits bleeding due to its effects on plasminogen conversion, approved by the FDA to treat menorrhagia and prevent bleeding in hemophilia patients undergoing dental extraction.
Nabila Scabine Pessotti +7 more
wiley +1 more source
Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes [PDF]
, 2014 Allen, G +7 more
core
Universal base editing for hemophilia B [PDF]
Nemekhbayar Baatartsogt +16 more
openalex +1 more source